🔎 Trials Near Me

Home › Alpha-1 Antitrypsin Deficiency › South Carolina › Charleston

Alpha-1 Antitrypsin Deficiency clinical trials in Charleston, SC

6 studies for Alpha-1 Antitrypsin Deficiency are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

RecruitingPhase 1/2
  • Clinical Study Center, Charleston
Ages 18 to 75 · All sexes · Updated Oct 5, 2026 · NCT06389877

A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)

RecruitingPhase 1/2
  • Clinical Study Center, Charleston
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT07227207

A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems

RecruitingObservational study
  • University of South Carolina, Charleston
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT06512454

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

RecruitingPhase 3
  • Medical University of South Carolina, Charleston
Ages 18 to 75 · All sexes · Updated May 13, 2026 · NCT05677971

A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency

RecruitingPhase 1
  • Medical University of South Carolina, Charleston
Ages 18 to 70 · All sexes · Updated Jul 22, 2025 · NCT06049082

About Alpha-1 Antitrypsin Deficiency

Alpha-1 Antitrypsin Deficiency is an inherited condition that raises your risk for lung and liver disease. Learn about the symptoms and treatment.

More about Alpha-1 Antitrypsin Deficiency on MedlinePlus

Alpha-1 Antitrypsin Deficiency trials in other cities

Other studies in Charleston

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.